Allergan's Freedom From Expression Suit Challenges Gov't REMS, Off-Label Powers
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm wants to go beyond the REMS requirements and offer treatment guidance, not just risk information, about the use of Botox for spasticity, an unapproved condition.